Growth Metrics

Volitionrx (VNRX) Leases (2019 - 2025)

Volitionrx posted quarterly Leases of $495749.0 for Q4 2025, down 17.35% year-on-year from $599816.0 in Q4 2024, and down 13.37% on a QoQ basis from $572289.0 in Q3 2025.

Volitionrx (VNRX) has 7 years of Leases data on file, last reported at $495749.0 in Q4 2025.

  • For the quarter ending Q4 2025, Leases fell 17.35% year-over-year to $495749.0; the trailing twelve-month figure through Dec 2025 stood at $495749.0 (down 17.35% YoY), and the FY2025 full-year result was $495749.0, down 17.35% from the prior year.
  • Leases for Q4 2025 stood at $495749.0, down from $572289.0 in the prior quarter.
  • Across five years, Leases topped out at $830257.0 in Q1 2022 and bottomed at $263440.0 in Q3 2021.
  • The 5-year median for Leases is $569163.0 (2024), against an average of $555589.3.
  • The widest annual swing landed in 2022, when Leases surged 149.6%; it then dropped 28.56% in 2023.
  • A 5-year view of Leases shows it stood at $383551.0 in 2021, then surged by 61.49% to $619392.0 in 2022, then declined by 11.28% to $549504.0 in 2023, then climbed by 9.16% to $599816.0 in 2024, then declined by 17.35% to $495749.0 in 2025.
  • The last three Leases figures came in at $495749.0 (Q4 2025), $572289.0 (Q3 2025), and $635041.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 547.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 99.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 73.10 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 396.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 155.20 Mn
10 Volitionrx 101.83 Mn 99.36 Mn -1.01 Mn 495,749.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 495,749.00
Sep 30, 2025 572,289.00
Jun 30, 2025 635,041.00
Mar 31, 2025 560,610.00
Dec 31, 2024 599,816.00
Sep 30, 2024 635,857.00
Jun 30, 2024 512,317.00
Mar 31, 2024 569,163.00
Dec 31, 2023 549,504.00
Sep 30, 2023 490,468.00
Jun 30, 2023 530,669.00
Mar 31, 2023 593,108.00
Dec 31, 2022 619,392.00
Sep 30, 2022 657,557.00
Jun 30, 2022 739,015.00
Mar 31, 2022 830,257.00
Dec 31, 2021 383,551.00
Sep 30, 2021 263,440.00
Jun 30, 2021 318,393.00
Dec 31, 2020 326,085.00
Mar 31, 2020 330,131.00
Dec 31, 2019 381,483.00
Sep 30, 2019 193,918.00
Jun 30, 2019 179,158.00